Trial Profile
Efficacy and safety study of Entecavir and Telbivudine in patients with chronic Hepatitis-B over 5 years
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 May 2016
Price :
$35
*
At a glance
- Drugs Entecavir (Primary) ; Telbivudine (Primary)
- Indications Hepatitis B
- Focus Adverse reactions; Therapeutic Use
- 10 May 2016 New trial record
- 17 Apr 2016 Results of 5 year outcome study presented at The International Liver Congress™ 2016